Nicholas Teman
Concepts (365)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 42 | 2025 | 530 | 13.030 |
Why?
| | Coronary Artery Bypass | 13 | 2025 | 234 | 6.400 |
Why?
| | Extracorporeal Membrane Oxygenation | 18 | 2024 | 301 | 6.310 |
Why?
| | Thoracic Surgery | 11 | 2025 | 132 | 5.140 |
Why?
| | Postoperative Complications | 35 | 2025 | 2654 | 3.380 |
Why?
| | Operating Rooms | 6 | 2025 | 123 | 3.320 |
Why?
| | Surgeons | 10 | 2025 | 297 | 2.640 |
Why?
| | Intensive Care Units | 8 | 2024 | 827 | 2.570 |
Why?
| | Pulmonary Embolism | 6 | 2024 | 226 | 2.200 |
Why?
| | Retrospective Studies | 68 | 2025 | 15657 | 2.130 |
Why?
| | Heart-Assist Devices | 8 | 2024 | 552 | 2.080 |
Why?
| | Failure to Rescue, Health Care | 3 | 2025 | 5 | 2.070 |
Why?
| | Airway Extubation | 4 | 2025 | 57 | 1.940 |
Why?
| | Coronary Artery Disease | 7 | 2025 | 698 | 1.930 |
Why?
| | Heart Valve Prosthesis Implantation | 8 | 2022 | 180 | 1.760 |
Why?
| | Heart Arrest | 5 | 2024 | 339 | 1.740 |
Why?
| | Heart Transplantation | 8 | 2025 | 754 | 1.650 |
Why?
| | Propensity Score | 6 | 2025 | 294 | 1.610 |
Why?
| | Treatment Outcome | 36 | 2025 | 10811 | 1.530 |
Why?
| | Elective Surgical Procedures | 2 | 2024 | 179 | 1.500 |
Why?
| | Cardiopulmonary Bypass | 5 | 2024 | 209 | 1.470 |
Why?
| | Tricuspid Valve Insufficiency | 5 | 2020 | 24 | 1.460 |
Why?
| | Length of Stay | 8 | 2025 | 1215 | 1.390 |
Why?
| | Sternotomy | 4 | 2022 | 26 | 1.370 |
Why?
| | Humans | 112 | 2025 | 137585 | 1.290 |
Why?
| | Biomedical Research | 4 | 2025 | 692 | 1.240 |
Why?
| | Aged | 41 | 2025 | 23961 | 1.200 |
Why?
| | Middle Aged | 48 | 2025 | 33479 | 1.180 |
Why?
| | Shock, Cardiogenic | 4 | 2024 | 63 | 1.100 |
Why?
| | Time Factors | 17 | 2025 | 6828 | 1.090 |
Why?
| | Hospital Mortality | 10 | 2024 | 911 | 1.070 |
Why?
| | Hospital Costs | 4 | 2025 | 117 | 1.060 |
Why?
| | Heparin | 3 | 2023 | 261 | 1.030 |
Why?
| | Internship and Residency | 7 | 2021 | 1147 | 1.020 |
Why?
| | Risk Factors | 23 | 2025 | 10388 | 0.990 |
Why?
| | Male | 60 | 2025 | 67762 | 0.970 |
Why?
| | Mitral Valve Insufficiency | 2 | 2018 | 68 | 0.960 |
Why?
| | Heart Failure | 6 | 2022 | 2236 | 0.960 |
Why?
| | Clinical Competence | 6 | 2021 | 1118 | 0.960 |
Why?
| | Patient Isolation | 1 | 2025 | 19 | 0.960 |
Why?
| | Registries | 8 | 2025 | 2035 | 0.940 |
Why?
| | Myocardial Infarction | 3 | 2024 | 1046 | 0.930 |
Why?
| | Education, Medical, Graduate | 3 | 2019 | 486 | 0.920 |
Why?
| | Non-ST Elevated Myocardial Infarction | 1 | 2025 | 22 | 0.920 |
Why?
| | Catheters | 2 | 2016 | 73 | 0.910 |
Why?
| | Health Care Costs | 3 | 2025 | 398 | 0.900 |
Why?
| | Advanced Cardiac Life Support | 1 | 2024 | 16 | 0.900 |
Why?
| | Atrial Appendage | 1 | 2024 | 17 | 0.880 |
Why?
| | Databases, Factual | 8 | 2024 | 1357 | 0.870 |
Why?
| | Delirium | 2 | 2024 | 92 | 0.850 |
Why?
| | Female | 55 | 2025 | 73304 | 0.850 |
Why?
| | Certification | 1 | 2024 | 113 | 0.820 |
Why?
| | Time-to-Treatment | 1 | 2025 | 205 | 0.810 |
Why?
| | Endovascular Procedures | 2 | 2020 | 312 | 0.800 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2020 | 128 | 0.790 |
Why?
| | Prosthesis Design | 5 | 2022 | 327 | 0.780 |
Why?
| | Critical Care | 4 | 2023 | 601 | 0.770 |
Why?
| | Thrombosis | 2 | 2023 | 371 | 0.760 |
Why?
| | Ventricular Dysfunction, Right | 2 | 2022 | 238 | 0.760 |
Why?
| | Heart Valve Prosthesis | 3 | 2022 | 114 | 0.760 |
Why?
| | Sternum | 3 | 2023 | 24 | 0.750 |
Why?
| | Device Removal | 2 | 2020 | 136 | 0.750 |
Why?
| | Subclavian Vein | 1 | 2021 | 15 | 0.740 |
Why?
| | Aortic Valve | 5 | 2022 | 351 | 0.730 |
Why?
| | Percutaneous Coronary Intervention | 3 | 2025 | 480 | 0.720 |
Why?
| | Venous Thromboembolism | 1 | 2025 | 316 | 0.710 |
Why?
| | Cost-Benefit Analysis | 3 | 2022 | 591 | 0.690 |
Why?
| | Ventricular Dysfunction | 1 | 2020 | 15 | 0.680 |
Why?
| | Thrombectomy | 2 | 2022 | 69 | 0.680 |
Why?
| | Atrial Fibrillation | 2 | 2024 | 388 | 0.670 |
Why?
| | Aortic Valve Stenosis | 5 | 2022 | 229 | 0.670 |
Why?
| | Endocarditis, Bacterial | 1 | 2020 | 41 | 0.670 |
Why?
| | Virginia | 6 | 2023 | 62 | 0.670 |
Why?
| | Financing, Organized | 1 | 2020 | 35 | 0.670 |
Why?
| | Endocarditis | 1 | 2020 | 37 | 0.670 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2020 | 43 | 0.660 |
Why?
| | Faculty, Medical | 3 | 2025 | 283 | 0.650 |
Why?
| | Catheterization, Central Venous | 1 | 2021 | 112 | 0.650 |
Why?
| | Lung Transplantation | 3 | 2024 | 313 | 0.640 |
Why?
| | Education, Medical | 1 | 2023 | 266 | 0.640 |
Why?
| | Hemorrhage | 2 | 2024 | 722 | 0.640 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 213 | 0.640 |
Why?
| | Recovery of Function | 1 | 2023 | 653 | 0.640 |
Why?
| | Respiratory Insufficiency | 2 | 2020 | 318 | 0.630 |
Why?
| | Organizational Policy | 1 | 2020 | 84 | 0.630 |
Why?
| | Purinergic P2Y Receptor Antagonists | 1 | 2020 | 66 | 0.630 |
Why?
| | Thrombocytopenia | 1 | 2021 | 200 | 0.620 |
Why?
| | Hippocampus | 1 | 2024 | 895 | 0.620 |
Why?
| | Risk Assessment | 13 | 2024 | 3457 | 0.620 |
Why?
| | Machine Learning | 1 | 2024 | 493 | 0.620 |
Why?
| | Electronic Mail | 1 | 2019 | 64 | 0.610 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2019 | 27 | 0.610 |
Why?
| | Rats, Sprague-Dawley | 1 | 2024 | 2486 | 0.610 |
Why?
| | Tracheostomy | 1 | 2020 | 133 | 0.590 |
Why?
| | Patient Transfer | 3 | 2019 | 176 | 0.590 |
Why?
| | Students, Medical | 1 | 2023 | 348 | 0.580 |
Why?
| | General Surgery | 3 | 2015 | 173 | 0.570 |
Why?
| | Survival Rate | 9 | 2024 | 1972 | 0.550 |
Why?
| | Shock, Septic | 1 | 2020 | 219 | 0.550 |
Why?
| | Adult | 25 | 2025 | 37929 | 0.540 |
Why?
| | Surgical Wound Infection | 2 | 2023 | 307 | 0.520 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 322 | 0.520 |
Why?
| | Aspirin | 1 | 2020 | 387 | 0.520 |
Why?
| | Educational Measurement | 2 | 2019 | 289 | 0.520 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2020 | 463 | 0.490 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 402 | 0.480 |
Why?
| | Stroke | 1 | 2024 | 1120 | 0.470 |
Why?
| | Transportation of Patients | 1 | 2015 | 55 | 0.450 |
Why?
| | Extracorporeal Circulation | 1 | 2014 | 13 | 0.450 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 283 | 0.440 |
Why?
| | Pulsatile Flow | 1 | 2014 | 60 | 0.440 |
Why?
| | Tissue Donors | 3 | 2025 | 425 | 0.430 |
Why?
| | Catheterization | 3 | 2024 | 179 | 0.430 |
Why?
| | Sepsis | 1 | 2020 | 617 | 0.420 |
Why?
| | Hemodynamics | 3 | 2022 | 1113 | 0.410 |
Why?
| | Anticoagulants | 4 | 2023 | 664 | 0.410 |
Why?
| | Specialties, Surgical | 1 | 2014 | 75 | 0.410 |
Why?
| | Jugular Veins | 1 | 2013 | 41 | 0.410 |
Why?
| | Tertiary Care Centers | 1 | 2014 | 160 | 0.410 |
Why?
| | Reoperation | 4 | 2022 | 573 | 0.410 |
Why?
| | Biomarkers | 1 | 2024 | 4149 | 0.410 |
Why?
| | Education, Medical, Continuing | 1 | 2014 | 127 | 0.400 |
Why?
| | Vasodilator Agents | 1 | 2015 | 331 | 0.400 |
Why?
| | Aortic Aneurysm | 1 | 2013 | 64 | 0.400 |
Why?
| | Internationality | 1 | 2013 | 155 | 0.390 |
Why?
| | Myocardial Ischemia | 1 | 2014 | 263 | 0.390 |
Why?
| | Aorta, Thoracic | 1 | 2014 | 267 | 0.370 |
Why?
| | Decision Making | 1 | 2019 | 900 | 0.360 |
Why?
| | Thromboembolism | 1 | 2012 | 119 | 0.360 |
Why?
| | Esophagectomy | 1 | 2012 | 131 | 0.350 |
Why?
| | Acute Disease | 5 | 2024 | 1007 | 0.350 |
Why?
| | Patient Positioning | 2 | 2021 | 67 | 0.330 |
Why?
| | Oxygen | 1 | 2015 | 931 | 0.330 |
Why?
| | Sarcopenia | 2 | 2024 | 83 | 0.320 |
Why?
| | Preoperative Care | 1 | 2012 | 362 | 0.320 |
Why?
| | United States | 10 | 2025 | 14841 | 0.320 |
Why?
| | Nitric Oxide | 1 | 2015 | 915 | 0.320 |
Why?
| | Cardiologists | 2 | 2019 | 45 | 0.310 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 249 | 0.310 |
Why?
| | Odds Ratio | 2 | 2023 | 1070 | 0.300 |
Why?
| | Esophageal Neoplasms | 1 | 2012 | 321 | 0.290 |
Why?
| | Transcatheter Aortic Valve Replacement | 2 | 2022 | 130 | 0.290 |
Why?
| | Frailty | 2 | 2024 | 170 | 0.290 |
Why?
| | Preoperative Period | 3 | 2019 | 129 | 0.280 |
Why?
| | Hypoxia | 1 | 2015 | 1112 | 0.280 |
Why?
| | Severity of Illness Index | 6 | 2020 | 2828 | 0.270 |
Why?
| | Survival Analysis | 4 | 2019 | 1325 | 0.260 |
Why?
| | Academic Medical Centers | 2 | 2020 | 512 | 0.260 |
Why?
| | Bioprosthesis | 3 | 2022 | 40 | 0.260 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2024 | 179 | 0.250 |
Why?
| | Acute Kidney Injury | 2 | 2025 | 815 | 0.250 |
Why?
| | Partial Thromboplastin Time | 2 | 2023 | 57 | 0.250 |
Why?
| | Incidence | 5 | 2025 | 2804 | 0.240 |
Why?
| | Michigan | 3 | 2017 | 109 | 0.240 |
Why?
| | Physicians | 1 | 2014 | 910 | 0.240 |
Why?
| | Patient Selection | 2 | 2019 | 696 | 0.240 |
Why?
| | Mitral Valve | 3 | 2024 | 88 | 0.240 |
Why?
| | Perfusion | 2 | 2018 | 213 | 0.230 |
Why?
| | Radial Artery | 1 | 2025 | 68 | 0.220 |
Why?
| | Ligation | 1 | 2024 | 92 | 0.220 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2024 | 42 | 0.220 |
Why?
| | Blood Transfusion | 2 | 2024 | 325 | 0.220 |
Why?
| | Lung Injury | 2 | 2017 | 219 | 0.220 |
Why?
| | Phlebotomy | 1 | 2024 | 21 | 0.210 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 93 | 0.210 |
Why?
| | Logistic Models | 4 | 2023 | 2074 | 0.210 |
Why?
| | Random Allocation | 1 | 2024 | 353 | 0.210 |
Why?
| | Social Class | 2 | 2023 | 282 | 0.210 |
Why?
| | Factor IX | 1 | 2023 | 48 | 0.210 |
Why?
| | Iatrogenic Disease | 1 | 2024 | 67 | 0.210 |
Why?
| | Factor VIIa | 1 | 2023 | 41 | 0.210 |
Why?
| | Blood Coagulation Factors | 1 | 2023 | 54 | 0.210 |
Why?
| | Transplant Recipients | 1 | 2025 | 184 | 0.210 |
Why?
| | Hospitals, Low-Volume | 1 | 2023 | 22 | 0.200 |
Why?
| | Renal Replacement Therapy | 1 | 2023 | 92 | 0.200 |
Why?
| | Publishing | 1 | 2025 | 147 | 0.200 |
Why?
| | Waiting Lists | 1 | 2025 | 266 | 0.200 |
Why?
| | Hospitals, High-Volume | 1 | 2023 | 44 | 0.200 |
Why?
| | Follow-Up Studies | 5 | 2019 | 5131 | 0.200 |
Why?
| | Coronary Angiography | 1 | 2025 | 317 | 0.200 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4295 | 0.200 |
Why?
| | Acute Lung Injury | 2 | 2018 | 287 | 0.200 |
Why?
| | Prognosis | 6 | 2020 | 4030 | 0.190 |
Why?
| | Cost Savings | 1 | 2022 | 84 | 0.190 |
Why?
| | Morbidity | 2 | 2020 | 324 | 0.190 |
Why?
| | Mentors | 2 | 2021 | 202 | 0.190 |
Why?
| | Tricuspid Valve | 2 | 2022 | 30 | 0.190 |
Why?
| | Pacemaker, Artificial | 2 | 2020 | 119 | 0.190 |
Why?
| | Surgical Drapes | 1 | 2021 | 2 | 0.190 |
Why?
| | Contrast Media | 1 | 2025 | 467 | 0.190 |
Why?
| | Medical Illustration | 1 | 2021 | 10 | 0.190 |
Why?
| | Schools, Medical | 1 | 2023 | 147 | 0.190 |
Why?
| | Punctures | 1 | 2021 | 40 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 4 | 2019 | 889 | 0.180 |
Why?
| | Suction | 1 | 2021 | 34 | 0.180 |
Why?
| | Renal Insufficiency | 1 | 2023 | 162 | 0.180 |
Why?
| | Bandages | 1 | 2021 | 37 | 0.180 |
Why?
| | Work-Life Balance | 1 | 2021 | 22 | 0.180 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.180 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1587 | 0.180 |
Why?
| | Tissue and Organ Procurement | 1 | 2025 | 321 | 0.180 |
Why?
| | Dilatation | 1 | 2021 | 67 | 0.180 |
Why?
| | United Kingdom | 1 | 2022 | 318 | 0.180 |
Why?
| | Antineoplastic Agents | 1 | 2012 | 2129 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2022 | 1289 | 0.170 |
Why?
| | Cohort Studies | 6 | 2020 | 5742 | 0.170 |
Why?
| | Checklist | 1 | 2021 | 93 | 0.170 |
Why?
| | Heart Block | 1 | 2020 | 42 | 0.170 |
Why?
| | Blood Coagulation | 1 | 2022 | 255 | 0.170 |
Why?
| | Vagus Nerve Injuries | 1 | 2020 | 2 | 0.170 |
Why?
| | Informed Consent | 1 | 2021 | 175 | 0.170 |
Why?
| | Disinfection | 1 | 2021 | 124 | 0.170 |
Why?
| | Coronary Artery Bypass, Off-Pump | 1 | 2020 | 10 | 0.170 |
Why?
| | Recombinant Proteins | 1 | 2023 | 1353 | 0.160 |
Why?
| | Swine | 3 | 2022 | 775 | 0.160 |
Why?
| | Cardiac Catheterization | 1 | 2023 | 530 | 0.160 |
Why?
| | Donor Selection | 1 | 2020 | 77 | 0.160 |
Why?
| | Societies, Medical | 1 | 2024 | 820 | 0.160 |
Why?
| | Vagus Nerve | 1 | 2020 | 86 | 0.160 |
Why?
| | Renal Dialysis | 1 | 2023 | 435 | 0.160 |
Why?
| | Teaching | 1 | 2021 | 224 | 0.160 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2019 | 21 | 0.160 |
Why?
| | Echocardiography, Transesophageal | 1 | 2019 | 96 | 0.150 |
Why?
| | Learning Curve | 1 | 2019 | 72 | 0.150 |
Why?
| | Research Support as Topic | 1 | 2019 | 119 | 0.150 |
Why?
| | Biological Products | 1 | 2022 | 216 | 0.150 |
Why?
| | Lipopolysaccharides | 1 | 2022 | 886 | 0.150 |
Why?
| | Warm Ischemia | 1 | 2018 | 12 | 0.140 |
Why?
| | Prosthesis Fitting | 1 | 2018 | 15 | 0.140 |
Why?
| | Psoas Muscles | 1 | 2018 | 13 | 0.140 |
Why?
| | Cardiac Valve Annuloplasty | 1 | 2017 | 2 | 0.140 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 25 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 209 | 0.140 |
Why?
| | Protective Agents | 1 | 2018 | 41 | 0.140 |
Why?
| | Sphingosine | 1 | 2018 | 46 | 0.140 |
Why?
| | Coronary Disease | 1 | 2020 | 385 | 0.140 |
Why?
| | Cardiac Pacing, Artificial | 1 | 2018 | 87 | 0.140 |
Why?
| | Lysophospholipids | 1 | 2018 | 80 | 0.140 |
Why?
| | Leadership | 1 | 2021 | 388 | 0.140 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2019 | 131 | 0.140 |
Why?
| | Patient Readmission | 1 | 2023 | 697 | 0.130 |
Why?
| | Workload | 2 | 2019 | 167 | 0.130 |
Why?
| | Drug Therapy, Combination | 1 | 2020 | 1066 | 0.130 |
Why?
| | Skin | 1 | 2021 | 752 | 0.130 |
Why?
| | Reperfusion Injury | 1 | 2019 | 279 | 0.130 |
Why?
| | Stents | 1 | 2020 | 527 | 0.130 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 257 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2023 | 708 | 0.120 |
Why?
| | Kidney | 1 | 2023 | 1468 | 0.120 |
Why?
| | Rats | 1 | 2024 | 5647 | 0.120 |
Why?
| | Animals | 6 | 2024 | 36940 | 0.120 |
Why?
| | Guideline Adherence | 1 | 2020 | 556 | 0.120 |
Why?
| | Partial Pressure | 1 | 2015 | 30 | 0.120 |
Why?
| | Formative Feedback | 1 | 2015 | 28 | 0.120 |
Why?
| | Patient Care Team | 1 | 2020 | 631 | 0.120 |
Why?
| | Blood Gas Analysis | 1 | 2015 | 74 | 0.120 |
Why?
| | Hepatectomy | 1 | 2016 | 251 | 0.110 |
Why?
| | Equipment Design | 1 | 2016 | 522 | 0.110 |
Why?
| | Hospitals | 1 | 2020 | 691 | 0.110 |
Why?
| | Comorbidity | 1 | 2020 | 1622 | 0.110 |
Why?
| | Staff Development | 1 | 2015 | 58 | 0.110 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1081 | 0.110 |
Why?
| | Myxoma | 1 | 2014 | 12 | 0.110 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1000 | 0.110 |
Why?
| | Pandemics | 1 | 2023 | 1639 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 2 | 2020 | 1313 | 0.110 |
Why?
| | Heart Neoplasms | 1 | 2014 | 50 | 0.110 |
Why?
| | Inflammation | 1 | 2024 | 2837 | 0.100 |
Why?
| | Echocardiography, Doppler | 1 | 2014 | 108 | 0.100 |
Why?
| | Administration, Inhalation | 1 | 2015 | 688 | 0.100 |
Why?
| | Hemolysis | 1 | 2014 | 206 | 0.100 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2012 | 43 | 0.100 |
Why?
| | Primary Prevention | 1 | 2014 | 196 | 0.090 |
Why?
| | Body Mass Index | 1 | 2020 | 2389 | 0.090 |
Why?
| | Mental Disorders | 1 | 2020 | 1077 | 0.090 |
Why?
| | Sheep | 1 | 2014 | 856 | 0.090 |
Why?
| | Aorta | 1 | 2014 | 417 | 0.090 |
Why?
| | Surgical Procedures, Operative | 1 | 2014 | 259 | 0.090 |
Why?
| | Data Collection | 1 | 2014 | 673 | 0.090 |
Why?
| | Recurrence | 1 | 2014 | 1060 | 0.080 |
Why?
| | Respiration, Artificial | 1 | 2015 | 645 | 0.080 |
Why?
| | Thoracotomy | 2 | 2022 | 75 | 0.080 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1809 | 0.080 |
Why?
| | Neoadjuvant Therapy | 1 | 2012 | 404 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2526 | 0.080 |
Why?
| | Echocardiography | 3 | 2018 | 642 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1483 | 0.080 |
Why?
| | Lung | 2 | 2022 | 4060 | 0.080 |
Why?
| | Heart Ventricles | 1 | 2014 | 788 | 0.070 |
Why?
| | Myocardium | 1 | 2014 | 1002 | 0.070 |
Why?
| | Algorithms | 1 | 2015 | 1704 | 0.070 |
Why?
| | Obesity | 1 | 2020 | 2992 | 0.070 |
Why?
| | Blood Pressure | 1 | 2014 | 1786 | 0.070 |
Why?
| | Multivariate Analysis | 2 | 2021 | 1509 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2016 | 2691 | 0.060 |
Why?
| | Publications | 1 | 2025 | 47 | 0.060 |
Why?
| | Efficiency | 1 | 2025 | 99 | 0.060 |
Why?
| | Mediastinum | 1 | 2023 | 23 | 0.050 |
Why?
| | Unemployment | 1 | 2023 | 43 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2020 | 7635 | 0.050 |
Why?
| | Tidal Volume | 1 | 2022 | 86 | 0.050 |
Why?
| | Ventilators, Mechanical | 1 | 2022 | 58 | 0.050 |
Why?
| | Lymph Node Excision | 1 | 2023 | 171 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2023 | 499 | 0.050 |
Why?
| | Surveys and Questionnaires | 1 | 2014 | 5778 | 0.040 |
Why?
| | Antibodies | 1 | 2023 | 410 | 0.040 |
Why?
| | Prospective Studies | 1 | 2013 | 7604 | 0.040 |
Why?
| | Employment | 1 | 2023 | 178 | 0.040 |
Why?
| | Travel | 1 | 2021 | 130 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 2031 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2023 | 307 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 113 | 0.040 |
Why?
| | Lymph Nodes | 1 | 2023 | 491 | 0.040 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 194 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 664 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2022 | 273 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2022 | 265 | 0.040 |
Why?
| | Acetaminophen | 1 | 2022 | 268 | 0.040 |
Why?
| | Heart | 1 | 2023 | 655 | 0.040 |
Why?
| | Pain Management | 1 | 2022 | 352 | 0.040 |
Why?
| | Neoplasm Staging | 1 | 2023 | 1389 | 0.040 |
Why?
| | North Carolina | 1 | 2018 | 110 | 0.040 |
Why?
| | Lung Abscess | 1 | 2018 | 7 | 0.040 |
Why?
| | Decompressive Craniectomy | 1 | 2018 | 8 | 0.040 |
Why?
| | Empyema, Pleural | 1 | 2018 | 12 | 0.040 |
Why?
| | Polytetrafluoroethylene | 1 | 2018 | 23 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 778 | 0.040 |
Why?
| | Organ Preservation Solutions | 1 | 2018 | 45 | 0.040 |
Why?
| | Graft Survival | 1 | 2020 | 535 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3295 | 0.030 |
Why?
| | Cerebral Hemorrhage | 1 | 2018 | 108 | 0.030 |
Why?
| | Death | 1 | 2018 | 119 | 0.030 |
Why?
| | Educational Status | 1 | 2019 | 470 | 0.030 |
Why?
| | Suture Techniques | 1 | 2018 | 122 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 816 | 0.030 |
Why?
| | Observer Variation | 1 | 2018 | 343 | 0.030 |
Why?
| | Organ Size | 1 | 2018 | 477 | 0.030 |
Why?
| | Myocarditis | 1 | 2018 | 100 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2022 | 785 | 0.030 |
Why?
| | Needs Assessment | 1 | 2018 | 376 | 0.030 |
Why?
| | Consensus | 1 | 2019 | 683 | 0.030 |
Why?
| | Cause of Death | 1 | 2017 | 434 | 0.030 |
Why?
| | Vaccination | 1 | 2023 | 1381 | 0.030 |
Why?
| | Stroke Volume | 1 | 2018 | 612 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2057 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2017 | 1266 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2734 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2020 | 2844 | 0.030 |
Why?
| | Curriculum | 1 | 2019 | 992 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2019 | 552 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3556 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1946 | 0.020 |
Why?
| | Fellowships and Scholarships | 1 | 2015 | 306 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2892 | 0.020 |
Why?
| | Child | 2 | 2022 | 21935 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3284 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2018 | 5757 | 0.020 |
Why?
| | Hospitalization | 1 | 2016 | 2199 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2014 | 6079 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2014 | 3566 | 0.010 |
Why?
| | Mice | 1 | 2018 | 17787 | 0.010 |
Why?
| | Infant | 1 | 2014 | 9465 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 11074 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 13209 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 21513 | 0.010 |
Why?
|
|
Teman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|